A shot at hepatitis prevention

Area of Science:

• Hepatology
• Infectious Diseases
• Public Health

Background:

• Hepatitis virus infections continue to pose a significant public health challenge.
• While vaccination has reduced prevalence, substantial numbers of new and chronic infections persist annually.
• Hepatitis A typically resolves without long-term issues, but Hepatitis B can lead to severe chronic conditions.

Purpose of the Study:

• To review the current landscape of hepatitis A and B infections in the US.
• To emphasize the ongoing need for vaccination programs.
• To differentiate the long-term implications of Hepatitis A versus Hepatitis B.

Main Methods:

• Review of recent epidemiological trends and infection statistics for Hepatitis A and B.
• Analysis of disease progression and sequelae associated with each virus.
• Assessment of the impact of vaccination on infection rates.

Main Results:

• An estimated 20,000 new Hepatitis A virus infections occur annually in the US.
• Up to 100,000 acute Hepatitis B virus infections and over 1 million chronic Hepatitis B infections are reported yearly.
• Hepatitis B infection carries a significant risk of progressing to cirrhosis and hepatocellular carcinoma.

Conclusions:

• Despite vaccination progress, significant burdens of Hepatitis A and B infections persist.
• Hepatitis B infection represents a more serious long-term health threat due to its potential for chronicity and severe complications.
• Vaccination remains a critical strategy for preventing debilitating and life-threatening hepatitis infections, particularly in at-risk populations.